trending Market Intelligence /marketintelligence/en/news-insights/trending/96tcn75uw_d2bcitkn8hua2 content esgSubNav
In This List

Alnylam adds board member; former board chairman resigns

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Alnylam adds board member; former board chairman resigns

Alnylam Pharmaceuticals Inc. appointed Margaret Hamburg to its board, effective Jan. 10, 2019.

Hamburg currently serves as foreign secretary for the National Academy of Medicine and president-elect of the American Association for the Advancement of Science.

In addition, Alnylam said that John Clarke resigned from the board, also effective Jan. 10, 2019. He is the managing partner of Cardinal Partners, the co-founding venture investor of Alnylam, and has served on the board since the company's founding in 2002 and served as board chairman from 2002 through 2015.

The Cambridge, Mass.-based biotechnology company develops treatments using RNA molecules to inhibit gene expression and translation.